- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04784130
Enhancing Diabetes and Hypertension Self-Management Rural Appalachian Patients In Patient-Centered Medical Homes
January 31, 2024 updated by: Ranjita Misra, West Virginia University
Enhancing Diabetes and Hypertension Self-Management for Rural Appalachian Patients In Patient-Centered Medical Homes
The goal of this R34 planning project is to test the feasibility and acceptability of a 12-week modified diabetes and hypertension self-management program using trained Health Coaches.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
West Virginians have one of the highest prevalence of comorbid diabetes and hypertension in the nation that pose an enormous disease and economic burden in this medically underserved state.
Self-management of these two commonly found chronic conditions are an essential component of comprehensive disease management.
The goal of this R34 planning project is to test the feasibility and acceptability of a 12-week culturally-tailored, multimodal, diabetes and hypertension self-management program with a core (diet and physical activity) versus core plus (diet, physical activity and medication adherence) to an enhanced usual care (EUC) control group.
Seventy-five eligible adults with comorbid diabetes and hypertension will be randomized with a 1:1:1 ratio, based on allocation sequence generated by the bio-statistician investigator in the team.
The study will examine the extent to which key components (diet, physical activity, and medication adherence) contribute to the differences in clinical outcomes (HbA1c and blood pressure) between three groups using quantitative and qualitative focus groups and the RE-AIM evaluation framework.
The longer term effects of the intervention will be evaluated in a subsequent R01 clinical trial.
Study Type
Interventional
Enrollment (Actual)
98
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
West Virginia
-
Morgantown, West Virginia, United States, 26501-9190
- Clark K. Sleeth Family Medicine Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 95 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- English speaking adults ≥ 18 years of age;
- co-occurring diagnosis of type 2 diabetes and hypertension
- body mass index ≥ 25.0
- willing to be randomized, and complete the intervention and all assessments.
Exclusion Criteria:
- currently pregnant or breastfeeding
- diagnosed with a severe mental illness
- have any condition that requires physical activity limitations or is contraindicated for the Dietary Assessment to Stop Hypertension (DASH) diet
- inability to complete the study protocol.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: DHSMP core
Dietary Modification and Physical Activity
|
Respondents will complete activity logs (step count, using pedometer) and surveys (two items from the Summary of Diabetes Self-care activities measure) for physical activity.
Respondents will complete food logs and surveys (three items from the Summary of Diabetes Self-care activities measure) for dietary intake.
|
|
Experimental: DHSMP core plus
Dietary Modification, physical activity and medication adherence
|
Respondents will complete activity logs (step count, using pedometer) and surveys (two items from the Summary of Diabetes Self-care activities measure) for physical activity.
Respondents will complete food logs and surveys (three items from the Summary of Diabetes Self-care activities measure) for dietary intake.
Respondents will provide information on their medication adherence using a survey (questionnaire - MMAS-8).
|
|
Active Comparator: DHSMP control
enhanced usual care-3 hours of education plus materials.
|
Respondents will complete activity logs (step count, using pedometer) and surveys (two items from the Summary of Diabetes Self-care activities measure) for physical activity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical outcomes-BP
Time Frame: 6 months after enrollment
|
Difference in BP between baseline and end of program
|
6 months after enrollment
|
|
Clinical Outcomes-A1c
Time Frame: 6 months after enrollment
|
Difference in A1c between baseline and end of program
|
6 months after enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Behavioral outcome - dietary modification for high fat foods; question
Time Frame: 6 months after enrollment
|
Dietary analysis will be based on consumption of high fat foods (such as red meat or full-fat dairy) at baseline and completion of the Program.
All participants will be assessed regarding the number of days they eat high fat foods using a survey question from the Summary of Diabetes Self-care activities measure by Toolbert et al., Diabetes Care, 2000.
"On how many of the last SEVEN DAYS did you eat high fat foods such as red meat or full-fat dairy products?"
0 1 2 3 4 5 6 7. Changes in mean number of days of eating high fat foods will be assessed at baseline and at the completion of the program.
|
6 months after enrollment
|
|
Behavioral outcome - healthy eating plan; questions
Time Frame: 6 months after enrollment
|
Dietary analysis will be based on following a healthy eating plan at baseline and completion of the Program.
All participants will be assessed regarding the number of days they followed a healthful eating plan using a survey question from the Summary of Diabetes Self-care activities measure by Toolbert et al., Diabetes Care, 2000.
"How many of the last SEVEN DAYS have you followed a healthful eating plan?" 0 1 2 3 4 5 6 7. Changes in mean number of days followed a healthy eating plan will be assessed at baseline and at the completion of the program.
|
6 months after enrollment
|
|
Behavioral outcome - dietary modification for fruits and vegetables; questions
Time Frame: 6 months after enrollment
|
Dietary analysis will be based on eating fruits and vegetables at baseline and completion of the Program.
All participants will be assessed regarding the number of days they eat five or more servings of fruits and vegetables using a survey question from the Summary of Diabetes Self-care activities measure by Toolbert et al., Diabetes Care, 2000.
"On how many of the last SEVEN DAYS did you eat five or more servings of fruits and vegetables?" 0 1 2 3 4 5 6 7. Changes in mean number of days of eating fruits and vegetables will be assessed at baseline and at the completion of the program.
|
6 months after enrollment
|
|
Behavioral outcome - Activity log; Step count, using pedometer
Time Frame: 6 months after enrollment
|
All participants will be asked to wear a pedometer to record their daily step count.
|
6 months after enrollment
|
|
Behavioral outcome - exercise; questions
Time Frame: 6 months after enrollment
|
All participants will be assessed regarding the number of days they exercise using two survey questions from the Summary of Diabetes Self-care activities measure by Toolbert et al., Diabetes Care, 2000.
The description of the questions are as follow: Q1. "On how many of the last SEVEN DAYS did you participate in at least 30 minutes of physical activity?
(please list the total minutes of continuous activity, including walking)" 0 1 2 3 4 5 6 7 & Q2.
"On how many of the last SEVEN DAYS did you participate in a specific exercise session (such as swimming, walking, biking) other than what you do around the house or as part of your work?" 0 1 2 3 4 5 6 7).
The total exercise score will be calculated by the mean number of days for the two questions).
Changes in mean number of days exercised will be assessed at baseline and at the completion of the program.
|
6 months after enrollment
|
|
Behavioral outcome - medication adherence; questions
Time Frame: 6 months after enrollment
|
Respondents will provide information on their medication adherence using a survey (questionnaire - MMAS-8).
Changes in medication adherence will be assessed at baseline and completion of the program.
|
6 months after enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2019
Primary Completion (Actual)
October 31, 2023
Study Completion (Actual)
October 31, 2023
Study Registration Dates
First Submitted
July 29, 2020
First Submitted That Met QC Criteria
March 3, 2021
First Posted (Actual)
March 5, 2021
Study Record Updates
Last Update Posted (Estimated)
February 1, 2024
Last Update Submitted That Met QC Criteria
January 31, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1908672206
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on Physical Activity
-
Zohra Institute of Health SciencesCompletedPhysical Activity and StressPakistan
-
Health Education Research Foundation (HERF)CompletedQuality of LifePakistan
-
University GhentCompleted
-
Centre Hospitalier Universitaire DijonWithdrawn
-
Fundacion para la Investigacion y Formacion en...CompletedImpaired CognitionSpain
-
Universidad Santo TomasEmory University; Universidad Pública de Navarra; Universidad de Granada; University... and other collaboratorsCompletedObesity | Lipid Metabolism Disorders | Mental Health Wellness 1 | Body Composition, Beneficial | Metabolic Syndrome X
-
University of NottinghamBiotechnology and Biological Sciences Research CouncilRecruitingMetabolic Syndrome | Sedentary Behavior | Age-related Cognitive Decline | Age-Related SarcopeniaUnited Kingdom
-
Upper Alsace UniversityUniversity Hospital, Strasbourg, France; Centre Hospitalier Universitaire de... and other collaboratorsRecruitingQuality of Life | EndometriosisFrance
-
Cardenal Herrera UniversityCompleted
-
Istituti Clinici Scientifici Maugeri SpACompleted